Amiodarone in COVID-19: let's not forget its potential for pulmonary toxicity. | Eur J Prev Cardiol;28(18): e52, 2022 02 09. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Amiodarone in COVID-19: let's not forget its potential for pulmonary toxicity.

Kow, Chia Siang; Hasan, Syed Shahzad.

Kow CS; School of Postgraduate Studies, International Medical University, 126, Jln Jalil Perkasa 19, Bukit Jalil, 57000 Kuala Lumpur, Federal Territory of Kuala Lumpur, Malaysia.
Hasan SS; Department of Pharmacy, University of Huddersfield, Queensgate, Huddersfield HD1 3DH, UK.

Eur J Prev Cardiol ; 28(18): e52, 2022 02 09.

Article in English | MEDLINE | ID: covidwho-1099596

Subject(s)

Amiodarone; COVID-19; Amiodarone/adverse effects; Humans; SARS-CoV-2

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Amiodarone Limits: Humans Language: English Journal: Eur J Prev Cardiol Year: 2022 Document Type: Article Affiliation country: Eurjpc

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Amiodarone Limits: Humans Language: English Journal: Eur J Prev Cardiol Year: 2022 Document Type: Article Affiliation country: Eurjpc